Treatment Patterns Among Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD): A Real-World Evidence Study

Accepted for presentation at Consortium of Multiple Sclerosis Centers (CMSC) 2026 Annual Meeting. Findings available upon request. Contact us for more information.

Previous PostContinuous Glucose Monitoring With Prandial Insulin Use Among Medicare Patients With Type 2 Diabetes Mellitus and Reductions in Diabetic Ketoacidosis Events
Next PostA Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data

Previous PostContinuous Glucose Monitoring With Prandial Insulin Use Among Medicare Patients With Type 2 Diabetes Mellitus and Reductions in Diabetic Ketoacidosis Events

Next PostA Comparative Assessment of Travel Burden and Productivity Loss for CAR T-Cell Therapy and Bispecific Antibody Treatment in Patients With Relapsed/Refractory LBCL Using U.S. Claims Data

Harness the power of data to improve healthcare outcomes and economics.

Discover how our solutions improve healthcare efficiency, outcomes, and economics.